Domestic price of Ustekinumab

Ustekinumab (Ustekinumab)The original drug has been launched in China and is included in the medical insurance. It is only reimbursed for patients who meet the indications. The price of the 130mg/26ml intravenous preparation may be more than 5,000 yuan per box, and the price of the 90mg: 1.0ml*1 subcutaneous injection preparation may be more than 8,000 yuan per box.

Ustekinumab is a drug indicated for the treatment of moderate to severe plaque psoriasis (Ps) in patients 6 years of age or older who require phototherapy or systemic Treatment; or the treatment of adults 6 years of age or older with active psoriatic arthritis (PsA); or the treatment of adult patients with moderately to severely active ulcerative colitis (UC); or the treatment of adult patients with moderately to severely active Crohn's disease.

The active substance in ustekinumabustekinumab is a monoclonal antibody, a protein designed to recognize and attach to a specific target in the body. Ustekinumab attaches to two messenger molecules in the immune system called interleukin 12 and interleukin 23. Both are involved in inflammation and other processes important in psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. By blocking their activity, ustekinumab reduces immune system activity and disease symptoms.

The specifications of ustekinumab’s original drug sold overseasThe price of 130mg/26ml intravenous preparation may be more than 2,000 US dollars per box, and the price of 45mg: 0.5ml*1 subcutaneous injection preparation may be more than 10,000 US dollars per box. There are currently no generic versions of ustekinumab produced in other overseas countries. For more overseas drugs specific prices and details, please consult Yaode Medical Consultant.